By Nick Robertson ( October 23, 2025, 21:39 GMT | Insight) -- Western biopharma firms are looking to China for new treatments, with Roche, Gilead and AviadoBio each reaching licensing agreements for novel Chinese-developed therapies. Patent licensing news was led by pharmaceutical companies in recent weeks, with Roche, Gilead and AviadoBio each looking to China for novel therapies. LED lighting leaders Nichia and ams OSRAM also announced a broad cross-licensing agreement covering thousands of patents... Read more on MLex.